| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |